A detailed history of White Knight Strategic Wealth Advisors, LLC transactions in Amgen Inc stock. As of the latest transaction made, White Knight Strategic Wealth Advisors, LLC holds 2,637 shares of AMGN stock, worth $776,675. This represents 0.8% of its overall portfolio holdings.

Number of Shares
2,637
Previous 2,676 1.46%
Holding current value
$776,675
Previous $836,000 1.56%
% of portfolio
0.8%
Previous 0.86%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$309.38 - $337.38 $12,065 - $13,157
-39 Reduced 1.46%
2,637 $849,000
Q2 2024

Aug 14, 2024

SELL
$262.75 - $319.31 $20,757 - $25,225
-79 Reduced 2.87%
2,676 $836,000
Q1 2024

May 15, 2024

SELL
$268.87 - $324.56 $27,693 - $33,429
-103 Reduced 3.6%
2,755 $783,000
Q4 2023

Feb 13, 2024

SELL
$255.7 - $288.46 $57,532 - $64,903
-225 Reduced 7.3%
2,858 $823,000
Q3 2023

Nov 14, 2023

SELL
$218.65 - $271.46 $116,540 - $144,688
-533 Reduced 14.74%
3,083 $828,000
Q2 2023

Aug 11, 2023

BUY
$214.27 - $253.37 $182,129 - $215,364
850 Added 30.73%
3,616 $802,000
Q1 2023

May 15, 2023

BUY
$225.79 - $275.2 $53,286 - $64,947
236 Added 9.33%
2,766 $669,000
Q4 2022

Feb 14, 2023

SELL
$229.03 - $291.01 $21,757 - $27,645
-95 Reduced 3.62%
2,530 $664,000
Q3 2022

Nov 14, 2022

SELL
$224.46 - $253.15 $35,015 - $39,491
-156 Reduced 5.61%
2,625 $592,000
Q2 2022

Aug 15, 2022

SELL
$230.71 - $256.74 $18,456 - $20,539
-80 Reduced 2.8%
2,781 $677,000
Q1 2022

Apr 22, 2022

SELL
$219.27 - $242.57 $74,990 - $82,958
-342 Reduced 10.68%
2,861 $692,000
Q4 2021

Jan 14, 2022

BUY
$198.88 - $227.6 $637,012 - $729,002
3,203 New
3,203 $721,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $158B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track White Knight Strategic Wealth Advisors, LLC Portfolio

Follow White Knight Strategic Wealth Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of White Knight Strategic Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on White Knight Strategic Wealth Advisors, LLC with notifications on news.